NCT02665845 Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis). Status COMPLETED Phase PHASE3
NCT02647866 Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT02640391 Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis Status COMPLETED Phase N/A
NCT02632175 Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT02622139 Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD) Status COMPLETED Phase NA
NCT02620514 Medication Adherence in Patients With Inflammatory Bowel Disease (IBD) Status COMPLETED Phase NA
NCT02618187 A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis Status COMPLETED Phase PHASE1
NCT02610569 Comparison of PillCamCOLON (C2) Capsule and Standard Endoscopy for the Evaluation of Patients With Ulcerative Colitis Status COMPLETED Phase NA
NCT02606032 Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT02589665 A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT02586259 Effectiveness of Cortiment® in Patients With Ulcerative Colitis Status COMPLETED Phase N/A
NCT02579733 Azathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative Colitis Status TERMINATED Phase PHASE4
NCT02575040 Efficacy of Fecal Microbiota Transplantation for Inflammatory Bowel Disease Status UNKNOWN Phase PHASE3
NCT02550158 A Study Evaluating the Impact of an Educational Program (EDU-MICI) on Patients With Inflammatory Bowel Disease Status COMPLETED Phase NA
NCT02542917 Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study Status COMPLETED Phase N/A
NCT02539368 Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT02536404 Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT02531126 An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT02522780 Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC) Status COMPLETED Phase PHASE3